Videos
Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate Cancer – Daniel Spratt
Alicia Morgans and Daniel Spratt discuss an AI-derived multi-modal digital pathology-based biomarker test designed towards im [...]
Videos
Dr. Spratt Highlights the Validation of an MMAI Prognostic Biomarker for Prostate Cancer
Urology Times features a video of Daniel Spratt, MD discussing results demonstrating successful validation of ArteraAI’s MMAI [...]
Videos
Artificial Intelligence Transformative in Prostate Cancer Patient Care – Felix Feng
Felix Feng joins Alicia Morgans to discuss how the application of artificial intelligence (AI) is transformative in prostate [...]
Videos
Who is ARTERA? – Andre Esteva
Andre Esteva, CEO of ArteraAI joins Alicia Morgans in a discussion about ArteraAI, which has developed an artificial intellig [...]
Videos
Beyond Genomics: AI Informing Decision Making in Prostate Cancer – Ashley Ross
In this conversation, Alicia Morgans and Ashley Ross discuss the current clinical landscape of how risk is defined in localiz [...]